Strata Skin Sciences is a medical technology company in dermatology. Co. is engaged in developing, commercializing and marketing products for the treatment of dermatologic conditions. Co.'s products include the XTRAC® and Pharos® excimer lasers and VTRAC® lamp systems utilized in the treatment of psoriasis, vitiligo and various other skin conditions, as well as the TheraClear® X Acne Therapy System utilized in the treatment of acne-related skin conditions. The XTRAC and Pharos excimer laser technology emits ultraviolet light targeted primarily towards autoimmune dermatological skin disorders such as psoriasis, vitiligo, atopic dermatitis, and eczema, among others. We show 28 historical shares outstanding datapoints in our coverage of SSKN's shares outstanding history.
Understanding the changing numbers of SSKN shares outstanding — and
comprehending the concept of differing number of shares outstanding in general comparing companies like SSKN versus peers —
is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at
a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies.
Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history.
With this page we aim to empower investors researching SSKN by allowing them to research SSKN shares outstanding history
as well as any other stock in our coverage universe. |
Free SSKN Email Alerts:
Video: Shares Outstanding Importance
